ABSTRACT Filter mud is an industrial waste produced by sugar crops during the sugar production process, which contains N, P, K, organic matter, and a variety of trace elements required for plant growth. Therefore, a soil cultivation experiment was devised to verify the effects of applying diverse proportions of filter mud on the growth and physiological variations of sugar beet (Beta vulgaris L. subsp. vulgaris) seedlings. For this study, sugar mill filter mud equivalent to 1%, 3%, 5%, 7%, 9%, 11%, and 13% of the dry weight of neutral black soil was used. Sugar beet seeds were planted in soil with filter mud and their growth, nutrient, and physiological indexes are measured after they grew into sugar beet seedlings. After the application of filter mud, the growth status of sugar beet seedlings increased significantly compared to the non-application of filter mud. Soil application of filter mud increases the content of inorganic N, available P, available K, and organic matter in the soil. And the most pronounced growth of sugar beet seedlings was achieved at 7% of the applied filter mud. In addition, the content of chlorophyll, transpiration rate, net photosynthetic rate, stomatal conductance, and phosphoenolpyruvate carboxylase activity all increased significantly. As a result, it was determined that filter mud from sugar beet waste was an effective soil improver material, a certain percentage of filter mud can promote the growth of sugar beet seedlings. This has important implications for the improvement of sugar beet yields and the recycling of agricultural wastes.

RESUMO Introdução O ciclismo é um esporte de competição e tem altas exigências para os próprios atletas, tais como o uso versátil de habilidades, aptidão física e explosividade. Objetivo Aumentar a resistência de velocidade específica dos atletas. Métodos Catorze proeminentes ciclistas masculinos de curta distância foram divididos em um grupo de número constante de ciclistas (grupo CG, n=7) e um grupo de número decrescente de ciclistas (grupo DG, n=7), submetidos a um protocolo de treinamento físico. Resultados Os picos de atividade e média de resistência sofrem uma melhoria nos dois grupos de atletas, períodos de repouso melhoraram significativamente em comparação com os anteriores, a desaceleração diminuiu 12,2% e 14,6% nos grupos CG e DG, respectivamente, imediatamente após o final do período de repouso. A latência diminuiu significativamente em ambos os grupos (P<0,05). Conclusão Em comparação com o programa com o mesmo número de pedaladas, a carga de treinamento no estágio baseado no programa piloto com o número decrescente de pedaladas foi maior, o efeito do treinamento foi mais significativo na melhoria da potência de pico, na capacidade de manutenção de potência de 1 km total e no limiar anaeróbico. A relação do fornecimento de energia do metabolismo aeróbico durante o exercício com intensidade acima da intensidade também foi aprimorada. Nível de evidência II; Estudos terapêuticos - investigação dos resultados do tratamento.

ABSTRACT Introduction Cycling is a competitive sport and has high demands on the athletes themselves, such as versatile use of skills, physical fitness, and explosiveness. Objective Increase the specific speed endurance of athletes. Methods Fourteen prominent male short-distance cyclists were divided into a group of constant cyclists (CG group, n=7) and a group of decreasing cyclists (DG group, n=7) and subjected to a physical training protocol. Results Peak activity and average endurance improved in both groups of athletes; rest periods improved significantly compared to the previous ones, and deceleration decreased by 12.2% and 14.6% in the CG and DG groups, respectively, immediately after the end of the rest period. Latency decreased significantly in both groups (P<0.05). Conclusion Compared with the program with the same number of rides, the training load in the stage-based pilot program with the decreasing number of rides was higher, and the training effect was more significant in the improvement of peak power, 1 km total power maintenance capacity, and anaerobic threshold. The energy supply ratio of aerobic metabolism during exercise at the above intensity was also improved. Level of evidence II; Therapeutic studies - investigation of treatment outcomes.

RESUMEN Introducción El ciclismo es un deporte de competición y tiene grandes exigencias para los propios atletas, como el uso versátil de las habilidades, la aptitud física y la explosividad. Objetivo Aumentar la resistencia a la velocidad específica de los atletas. Métodos Catorce destacados ciclistas masculinos de corta distancia fueron divididos en un grupo de número constante de ciclistas (grupo CG, n=7) y un grupo de número decreciente de ciclistas (grupo DG, n=7), sometidos a un protocolo de entrenamiento físico. Resultados La actividad máxima y la resistencia media experimentan una mejora en ambos grupos de atletas, los periodos de descanso mejoran significativamente en comparación con los anteriores, la desaceleración disminuye un 12,2% y un 14,6% en los grupos CG y DG, respectivamente, inmediatamente después de finalizar el periodo de descanso. La latencia disminuyó significativamente en ambos grupos (P<0,05). Conclusión En comparación con el programa con el mismo número de salidas, la carga de entrenamiento en el programa piloto basado en etapas con el número de salidas decreciente fue mayor, el efecto del entrenamiento fue más significativo en la mejora de la potencia máxima, la capacidad de mantenimiento de la potencia total en 1 km y el umbral anaeróbico. También mejoró la relación de suministro de energía del metabolismo aeróbico durante el ejercicio a una intensidad superior. Nivel de evidencia II; Estudios terapéuticos - investigación de los resultados del tratamiento.

Recombinant human peroxiredoxin-5 (hPRDX5), isolated from anti-cancer bioactive peptide (ACBPs), shows a homology of 89% with goat peroxiredoxin-5 (gPRDX5) and is reported to display anti-tumor activity in vivo. Herein, we explored the effect of hPRDX5 and the responsible mechanism in treating pancreatic cancer. Tumor-bearing mice were randomly divided into normal PBS group and treatment group (n=5; 10 mg/kg hPRDX5). Flow cytometry was employed to examine lymphocytes, myeloid-derived suppressor cell subsets, and the function proteins of natural killer (NK) cells in peripheral blood, spleen, and tumor tissues of mice. Western blot was used to measure the protein expressions of the key nodes in TLR4-MAPK-NF-κB signaling pathway. The rate of tumor suppression was 57.6% at a 10 mg/kg dose in orthotopic transplanted tumor mice. Moreover, the population of CD3+CD4+T cells, NK cells, and CD3+CD8+T cells was significantly increased in the tumor tissue of the hPRDX5 group, while the proportion of granulocytic-myeloid-derived suppressor cells decreased slightly. In addition, after treatment with hPRDX5, the percentage of NK cells in blood increased more than 4-fold. Our findings indicated that hPRDX5 effectively suppressed pancreatic cancer possibly via the TLR4-MAPK-NF-κB signaling cascade; hence hPRDX5 could be a prospective immunotherapy candidate for treating pancreatic cancer.

Abstract Objective: To investigate the impact of recombinant human interferon α1b (rhIFNα1b) treatment in infants hospitalized with lower respiratory tract infections on subsequent wheezing. Methods: The clinical data of infants (n = 540) with viral pneumonia, wheezy bronchitis, or bronchiolitis hospitalized in 19 Chinese hospitals from June 2009 to June 2015 were retrospectively analyzed. The parameters relevant to wheezing episodes within the last year were collected by telephone and questionnaires. The rhIFNα1b treatment group (n = 253) and control group (n = 287) were compared in terms of wheezing episodes within the last year. Moreover, the wheezing group (95 cases) and non-wheezing group (445 cases) were compared. Results: Out of 540 cases, 95 (17.6%) experienced wheezing episodes, 13.8% (35/253) cases treated with rhIFNα1b, and 20.9% (60/287) cases without rhIFNα1b experienced wheezing episodes within the last year. The rhIFNα1b treatment significantly improved wheezing episodes within the last year, compared with the control peers (p = 0.031). Single-factor regression showed statistically significant differences between the wheezing and non-wheezing groups in terms of age, rhIFNα1b use, childhood and family history of allergy, housing situation, and feeding history (p < 0.05). Binary logistic regression showed a childhood history of allergy (OR = 2.14, p = 0.004), no rhIFNα1b use (OR = 1.70, p = 0.028), and living in a crowded house (OR = 1.92, p = 0.012) might be risk factors of subsequent wheezing. Accordingly, breastfeeding (OR = 0.44, p = 0.008) and hospitalization age of 1-year-old (OR = 0.58, p = 0.024) were protective factors. Conclusions: Early use of rhIFNα1b in infants hospitalized with lower respiratory tract infections and breastfeeding could prevent subsequent wheezing. Living in a crowded house could promote subsequent wheezing.

RESUMO OBJETIVO RNAs longos não-codificantes (INcRNAs) são frequentemente expressos anormalmente em tumores e estão envolvidos na ocorrência e progressão do câncer humano. Recentemente, um INcRNA relacionado com a doença, o TMPO antisense RNA 1 (TMPO-AS1), foi identificado como desregulado em vários tumores. Por isso, procuramos demonstrar se o TMPO-AS1 poderia ser um marcador de prognóstico promissor para pacientes com carcinoma de células escamosas da laringe (LSCC). MÉTODOS RT-PCR foi realizado para medir as expressões do TMPO-AS1 em 187 espécimes de LSCC em comparação com espécimes normais correspondentes. Foram utilizados testes Qui-quadrado para determinar as associações entre as expressões do TMPO-AS1 e as características clínicas dos pacientes com LSCC. Em seguida, o desfecho clínico dos pacientes com LSCC que tinham uma expressão do TMPO-AS1 inferior ou superior foi analisado com ensaios Kaplan-Meier. Por último, o modelo de riscos proporcionais de Cox foi utilizado para avaliar o valor prognóstico do TMPO-AS1 e outras características clínicas. RESULTADOS Observamos que o TMPO-AS1 estava claramente super-regulado nos tecidos de LSCC humanos em comparação com os espécimes normais correspondentes (p<0,01). Expressões mais elevadas de TMPO-AS1 estavam positivamente associadas ao estágio clínico (p=0,020) e à metástase linfática (p=0,027). Um estudo clínico com 187 pacientes revelou que aqueles com expressões mais baixas de TMPO-AS1 tiveram uma sobrevida pior do que aqueles com expressões elevadas de TMPO-AS1 (p=0,0012). Além disso, o resultado de ensaios multivariados demonstrou que a expressão do TMPO-AS1 é um preditor independente para a sobrevida global de pacientes com LSCC. CONCLUSÕES TMPO-AS1 pode ser considerado uma molécula nova envolvida na progressão do LSCC, o que proporciona um possível biomarcador de prognóstico.

SUMMARY OBJECTIVE Long noncoding RNA (lncRNAs) are frequently abnormally expressed in tumors and involved in the occurrence and progression of human cancer. Recently, a disease-related lncRNA, TMPO antisense RNA 1 (TMPO-AS1), was identified to be dysregulated in several tumors. Hence, we aimed to demonstrate whether TMPO-AS1 could be a promising prognostic marker for patients with laryngeal squamous cell carcinoma (LSCC). METHODS RT-PCR was performed to test TMPO-AS1 expressions in 187 LSCC specimens compared with matched normal specimens. Chi-squared tests were used to determine the associations between TMPO-AS1 expressions and the clinicopathological characteristics of LSCC patients. Then, the clinical outcome of LSCC patients who had lower or higher TMPO-AS1 expression was analyzed using Kaplan-Meier assays. Finally, a Cox proportional hazards model was carried out to evaluate the prognostic values of TMPO-AS1 and other clinical features. RESULTS We found that TMPO-AS1 was distinctly upregulated in human LSCC tissues compared with corresponding normal specimens (p < 0.01). Higher expressions of TMPO-AS1 were observed to be positively associated with the clinical stage (p = 0.020) and lymph node metastasis (p = 0.027). A clinical study in 187 patients revealed that patients with TMPO-AS1 low expressions had poorer survival than those with TMPO-AS1 high expressions (p = 0.0012). In addition, the result of multivariate assays demonstrated TMPO-AS1 expression is an independent predictor for the overall survival of LSCC patients. CONCLUSIONS TMPO-AS1 might be considered a novel molecule involved in LSCC progression, which provides a possible prognostic biomarker.

Abstract Background: Cocaine- and amphetamine-regulated transcript (CART), discovered initially by via differential display RT-PCR analysis of brains of rats administered cocaine, is expressed mainly in central nervous system or neuronal origin cells, and is involved in a wide range of behaviors, such as regulation of food intake, energy homeostasis, and reproduction. The hens egg-laying rate mainly depends on the developmental status of follicles, expression of CART have not been identified from hen follicles, the regulatory mechanisms of CART biological activities are still unknown. The objective of this study was to characterize the mRNA expression of CART in hen follicular granulosa cells and determine CART peptide localization and regulatory role during follicular development. Methods: Small white follicles (1–2 mm in diameter) were treated for RNA isolation; Small white follicles (1–2 mm in diameter) and large white follicles (4–6 mm in diameter) were treated for immunohistochemical localization and large white follicles (4–6 mm in diameter), small yellow follicles (6–8 mm in diameter), large yellow follicles (9–12 mm in diameter), mature follicles (F5, F4, F3, F2, F1, >12 mm in diameter) were treated for RNA isolation and Real time PCR. Results: The results showed that full length of the CDS of hen CART was 336 bp encoding a 111 amino acid polypeptide. In the hen ovary, CART peptide was primarily localized to the theca layer, but not all, the oocyte and granulosa layer, with diffused, weaker staining than relative to the theca cell layer. Further, amount of CART mRNA was more (P < 0.05) in granulosa cells of 6–8 mm follicles compared with that in granulosa cells of other follicles. However, CART mRNA amount was greater in theca cells of 4–6 mm follicles relative to follicles of other sizes (P < 0.05). Conclusions: Results suggest that CART could play a potential role in developmental regulation of chicken follicles.